Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry

E. Arbelo, J. Brugada, C. Blomström-Lundqvist, C. Laroche, J. Kautzner, E. Pokushalov, P. Raatikainen, M. Efremidis, G. Hindricks, A. Barrera, A. Maggioni, L. Tavazzi, N. Dagres, . ,

. 2017 ; 38 (17) : 1303-1316.

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010847

Aims: The ESC-EHRA Atrial Fibrillation Ablation Long-Term registry is a prospective, multinational study that aims at providing an accurate picture of contemporary real-world ablation for atrial fibrillation (AFib) and its outcome. Methods and results: A total of 104 centres in 27 European countries participated and were asked to enrol 20-50 consecutive patients scheduled for first and re-do AFib ablation. Pre-procedural, procedural and 1-year follow-up data were captured on a web-based electronic case record form. Overall, 3630 patients were included, of which 3593 underwent an AFib ablation (98.9%). Median age was 59 years and 32.4% patients had lone atrial fibrillation. Pulmonary vein isolation was attempted in 98.8% of patients and achieved in 95-97%. AFib-related symptoms were present in 97%. In-hospital complications occurred in 7.8% and one patient died due to an atrioesophageal fistula. One-year follow-up was performed in 3180 (88.6%) at a median of 12.4 months (11.9-13.4) after ablation: 52.8% by clinical visit, 44.2% by telephone contact and 3.0% by contact with the general practitioner. At 12-months, the success rate with or without antiarrhythmic drugs (AADs) was 73.6%. A significant portion (46%) was still on AADs. Late complications included 14 additional deaths (4 cardiac, 4 vascular, 6 other causes) and 333 (10.7%) other complications. Conclusion: AFib ablation in clinical practice is mostly performed in symptomatic, relatively young and otherwise healthy patients. Overall success rate is satisfactory, but complication rate remains considerable and a significant portion of patients remain on AADs. Monitoring after ablation shows wide variations. Antithrombotic treatment after ablation shows insufficient guideline-adherence.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010847
003      
CZ-PrNML
005      
20180418134116.0
007      
ta
008      
180404s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/eurheartj/ehw564 $2 doi
035    __
$a (PubMed)28104790
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Arbelo, Elena $u Department of Cardiology, Cardiovascular Institute. Hospital Clínic de Barcelona. University of Barcelona, Barcelona, Spain.
245    10
$a Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry / $c E. Arbelo, J. Brugada, C. Blomström-Lundqvist, C. Laroche, J. Kautzner, E. Pokushalov, P. Raatikainen, M. Efremidis, G. Hindricks, A. Barrera, A. Maggioni, L. Tavazzi, N. Dagres, . ,
520    9_
$a Aims: The ESC-EHRA Atrial Fibrillation Ablation Long-Term registry is a prospective, multinational study that aims at providing an accurate picture of contemporary real-world ablation for atrial fibrillation (AFib) and its outcome. Methods and results: A total of 104 centres in 27 European countries participated and were asked to enrol 20-50 consecutive patients scheduled for first and re-do AFib ablation. Pre-procedural, procedural and 1-year follow-up data were captured on a web-based electronic case record form. Overall, 3630 patients were included, of which 3593 underwent an AFib ablation (98.9%). Median age was 59 years and 32.4% patients had lone atrial fibrillation. Pulmonary vein isolation was attempted in 98.8% of patients and achieved in 95-97%. AFib-related symptoms were present in 97%. In-hospital complications occurred in 7.8% and one patient died due to an atrioesophageal fistula. One-year follow-up was performed in 3180 (88.6%) at a median of 12.4 months (11.9-13.4) after ablation: 52.8% by clinical visit, 44.2% by telephone contact and 3.0% by contact with the general practitioner. At 12-months, the success rate with or without antiarrhythmic drugs (AADs) was 73.6%. A significant portion (46%) was still on AADs. Late complications included 14 additional deaths (4 cardiac, 4 vascular, 6 other causes) and 333 (10.7%) other complications. Conclusion: AFib ablation in clinical practice is mostly performed in symptomatic, relatively young and otherwise healthy patients. Overall success rate is satisfactory, but complication rate remains considerable and a significant portion of patients remain on AADs. Monitoring after ablation shows wide variations. Antithrombotic treatment after ablation shows insufficient guideline-adherence.
650    _2
$a antikoagulancia $x terapeutické užití $7 D000925
650    _2
$a fibrilace síní $x chirurgie $7 D001281
650    _2
$a katetrizační ablace $x škodlivé účinky $x metody $x statistika a číselné údaje $7 D017115
650    _2
$a Evropa $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a hospitalizace $x statistika a číselné údaje $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a délka pobytu $x statistika a číselné údaje $7 D007902
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pooperační komplikace $x etiologie $7 D011183
650    _2
$a předoperační péče $7 D011300
650    _2
$a prospektivní studie $7 D011446
650    _2
$a registrace $7 D012042
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Brugada, Josep $u Department of Cardiology, Cardiovascular Institute. Hospital Clínic de Barcelona. University of Barcelona, Barcelona, Spain.
700    1_
$a Blomström-Lundqvist, Carina $u Department of Cardiology, Institution of Medical Science, Uppsala University, Uppsala, Sweden.
700    1_
$a Laroche, Cécile $u EURObservational Research Programme, European Society of Cardiology, Sophia-Antipolis, France.
700    1_
$a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Pokushalov, Evgeny $u Arrhythmia Department and EP Laboratory, State Research Institute of Circulation Pathology, Novosibirsk, Russian Federation.
700    1_
$a Raatikainen, Pekka $u Heart Center Co. Tampere University Hospital, Tampere, Finland.
700    1_
$a Efremidis, Michael $u Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, "Evangelismos" General Hospital of Athens, Athens, Greece.
700    1_
$a Hindricks, Gerhard $u Department of Electrophysiology, University Leipzig - Heart Center, Leipzig, Germany.
700    1_
$a Barrera, Alberto $u Arrhythmia Unit, Cardiology Department, University Hospital Virgen de la Victoria, Malaga.
700    1_
$a Maggioni, Aldo $u EURObservational Research Programme, European Society of Cardiology, Sophia-Antipolis, France. Associazione Nazionale Medici Cardiologi Ospedalieri Research Center (AMCO Research Center), Florence, Italy.
700    1_
$a Tavazzi, Luigi $u GVM Care and Research, E.S. Health Science Foundation, Maria Cecilia Hospital, Cotignola, Italy.
700    1_
$a Dagres, Nikolaos $u Department of Electrophysiology, University Leipzig - Heart Center, Leipzig, Germany.
700    1_
$a ,
773    0_
$w MED00009622 $t European heart journal $x 1522-9645 $g Roč. 38, č. 17 (2017), s. 1303-1316
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28104790 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180418134216 $b ABA008
999    __
$a ok $b bmc $g 1288332 $s 1007659
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 38 $c 17 $d 1303-1316 $i 1522-9645 $m European heart journal $n Eur Heart J $x MED00009622
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace